Direkt zum Inhalt
Merck
  • Decreased oxidant-induced proteolysis in erythrocytes with enhanced antioxidative defence enzymes due to Down's syndrome.

Decreased oxidant-induced proteolysis in erythrocytes with enhanced antioxidative defence enzymes due to Down's syndrome.

Clinica chimica acta; international journal of clinical chemistry (1991-05-15)
G Bartosz, J Kedziora, W Retelewska
ZUSAMMENFASSUNG

Erythrocytes of Down syndrome patients, having increased activity of superoxide dismutase and glutathione peroxidase, showed a similar increase in intracellular proteolysis upon stimulation with 1 mmol/l phenylhydrazine than normal erythrocytes. There were no differences in the magnitude of Heinz body formation following the treatment or in the proteolysis of exogenous oxidized substrate. These results demonstrate a protective role for endogenous antioxidative enzymes in the protein damage by oxidative stress which triggers intracellular proteolysis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
1-Acetyl-2-Phenylhydrazin, ≥98%